4 min read

EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Jul 15, 2026

20 signals (from 52 total). Consumer Cyclical leads (10). price range $13-$1093. 1 with insider buying. 3 with insider selling.

What This Signal Is

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

Market Context

Equity markets are trading in a constructive risk-on environment, with the Nasdaq leading gains at +0.60% and the Dow Jones adding a modest +0.29%, suggesting technology and growth-oriented names are attracting capital relative to more defensive, value-weighted segments. This divergence in index performance is consistent with a market rewarding momentum, which creates a favorable backdrop for EMA-based crossover signals that rely on sustained directional moves rather than mean-reversion dynamics.

Volatility conditions are notably supportive for trend-following strategies. The VIX sitting at 15.69 — down nearly 5% on the session — indicates a meaningful compression in implied volatility, which typically reduces the frequency of false breakouts and choppy intraday reversals that can undermine EMA crossover reliability. At this level, the VIX is neither complacently low nor elevated enough to signal hedging demand, suggesting traders are comfortable extending risk, which tends to improve signal follow-through on both the long and short side.

The concentration of signals in Consumer Cyclical is particularly relevant given the current market tone. This sector tends to outperform when risk appetite is strong and consumer confidence is holding, both of which align with today's price action. Sector rotation into Consumer Cyclical often reflects expectations of durable economic momentum, which can amplify trending behavior in individual names — precisely the condition where EMA10/EMA30 crossovers generate their strongest risk-reward setups. With 52 total signals generated, the breadth suggests broad participation rather than isolated pockets of activity, adding further conviction to the trend narrative.

🟢 Buy Signals (15 of 33 total)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 AMZN Amazon.com, Inc. Consumer Cyclical $254.96 $2742.6B
2 ARR ARMOUR Residential REI... Real Estate $17.30 $2.1B
3 BAM Brookfield Asset Manag... Financial Services $49.02 $78.3B
4 BIP Brookfield Infrastruct... Utilities $38.73 $17.9B
5 BLK BlackRock, Inc. Financial Services $1093.40 $169.5B
6 BSY Bentley Systems, Incor... Technology $31.54 $9.2B
7 CHD Church & Dwight Co., Inc. Consumer Defensive $97.11 $23.0B
8 CHWY Chewy, Inc. Consumer Cyclical $21.21 $8.8B
9 CX CEMEX, S.A.B. de C.V. Basic Materials $13.07 $19.0B
10 DHT DHT Holdings, Inc. Energy $18.01 $2.9B
11 ENB Enbridge Inc. Energy $56.15 $122.6B
12 GME GameStop Corp. Consumer Cyclical $22.26 -$248,074 $10.0B
13 IMO Imperial Oil Limited Energy $120.42 $59.9B
14 JD JD.com, Inc. Consumer Cyclical $29.28 -$45,564 $39.5B
15 LPG Dorian LPG Ltd. Energy $42.03 $1.8B

🔴 Sell Signals (5 of 19 total)

Ranked by RSI (higher RSI for sell signals = more overbought)

# Ticker Company Sector Price Insider MCap
1 ALNY Alnylam Pharmaceutical... Healthcare $279.14 $37.3B
2 ARWR Arrowhead Pharmaceutic... Healthcare $71.82 $10.1B
3 BNTX BioNTech SE Healthcare $91.99 $23.3B
4 CELC Celcuity Inc. Healthcare $91.51 $4.5B
5 CRSP CRISPR Therapeutics AG Healthcare $51.37 $5.0B

Field Notes

Sector concentration: Consumer Cyclical (10), Technology (10), Healthcare (7)

Insider selling: GME (GameStop Corp., -$248,074), JD (JD.com, Inc., -$45,564)

Data coverage: 11.5% insider, 19.2% congressional, 0.0% earnings, 9.6% news

Peer Analysis

ARR (ARMOUR Residential REIT, Inc.): Leads 5 peers: DX ($13.32), FBRT ($8.08), PMT ($9.83), ARI ($10.54), EPR ($60.13)

ALNY (Alnylam Pharmaceuticals, Inc.): Leads 5 peers: ARGX ($862.93), REGN ($664.45), IDXX ($557.02), BDX ($154.88), ZTS ($74.53)

Congressional Activity

NVDA (NVIDIA Corporation) 🔴 Bearish

  • 10 transactions: 2 purchases, 8 sales

TMUS (T-Mobile US, Inc.) 🔴 Bearish

  • 1 sale by 1 member

LRCX (Lam Research Corporation) 🔴 Bearish

  • 2 sales by 2 members

BLK (BlackRock, Inc.) 🔴 Bearish

  • 1 sale by 1 member

AMZN (Amazon.com, Inc.) 🔴 Bearish

  • 1 sale by 1 member

CHD (Church & Dwight Co., Inc.) 🔴 Bearish

  • 1 sale by 1 member

IBM (International Business Machines Corporation) 🟢 Bullish

  • 2 purchases by 2 members

TSM (Taiwan Semiconductor Manufacturing Company Limited) 🟢 Bullish

  • 3 purchases by 2 members

TDG (TransDigm Group Incorporated) 🟢 Bullish

  • 1 purchase by 1 member

IHG (InterContinental Hotels Group PLC) 🟢 Bullish

  • 1 purchase by 1 member

Recent Headlines

AMZN (Amazon.com, Inc.)

  • Better Artificial Intelligence (AI) Stock: Amazon vs. Alphabet
  • AWS EC2 and AI leader Dave Brown to exit, replaced by Amazon exec and Microsoft vet Dave Treadwell
  • Amazon senior cloud executive departs after 18 years

BIP (Brookfield Infrastructure Partners L.P.)

  • Crypto Corner: BIP-110's Blockchain Impact & Bitcoin's Bear Market Trough

BLK (BlackRock, Inc.)

  • BlackRock Surges as Megacap Tech Lifts Nasdaq
  • BlackRock Q2: I Was Wrong - It's A Buy Now (Rating Upgrade)

CELC (Celcuity Inc.)

  • Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans Transcript

Vlad's Take

Today's signals: Strong sector concentration in Consumer Cyclical (10 signals) suggests sector-specific rotation. 1 signal with insider buying adds conviction. 3 signals showing insider selling warrant caution. 4 signals with congressional buying shows lawmaker confidence. 6 signals with congressional selling warrant attention.

Trading tips for this strategy:

  • Entry timing: Enter on pullback after crossover or at crossover close price
  • Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
  • Stop loss: Below recent swing low for buys, above recent swing high for sells
  • Take profit: 5-10% target for swings, or trail stop at EMA10
  • Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)

Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.